XBiotech Inc. Faces Delisting Notice

Ticker: XBIT · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1626878

Xbiotech Inc. 8-K Filing Summary
FieldDetail
CompanyXbiotech Inc. (XBIT)
Form Type8-K
Filed DateApr 7, 2025
Risk Levelhigh
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, regulatory-filing

Related Tickers: XBI

TL;DR

XBiotech got a delisting notice, stock might be in trouble.

AI Summary

XBiotech Inc. filed an 8-K on April 7, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, effective April 1, 2025. The company is incorporated in British Columbia, Canada, and its principal executive offices are located in Austin, Texas.

Why It Matters

This filing indicates potential issues with XBiotech Inc.'s continued listing on an exchange, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to its operations and investors.

Key Players & Entities

  • XBiotech Inc. (company) — Registrant
  • April 1, 2025 (date) — Earliest event reported
  • April 7, 2025 (date) — Date of report
  • 5217 Winnebago Ln, Austin, TX 78744 (location) — Principal executive offices

FAQ

What specific listing rule or standard did XBiotech Inc. fail to satisfy?

The filing does not specify the exact rule or standard that XBiotech Inc. failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.

When was the notice of delisting or failure to satisfy a continued listing rule or standard issued?

The earliest event reported in the filing is April 1, 2025, and the filing date is April 7, 2025.

What is XBiotech Inc.'s state of incorporation?

XBiotech Inc. is incorporated in British Columbia, Canada.

Where are XBiotech Inc.'s principal executive offices located?

XBiotech Inc.'s principal executive offices are located at 5217 Winnebago Ln, Austin, TX 78744.

What is the Commission File Number for XBiotech Inc.?

The Commission File Number for XBiotech Inc. is 001-37347.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding XBiotech Inc. (XBIT).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.